CD44 and breast carcinoma: At first glance, our data seems to be in conflict with current assertions that CD44+/CD24-/low subpopulation with tumour-initiating properties is positively correlated with distant metastasis in breast cancer [32], and this subpopulation enriched in TNBC subtype is associated with poor outcome of patients [29].